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Conclusions. The relative roles of surgery and RT are controversial. The are proponents of a predominantly surgical approach
while others favor minimal surgery followed by adjuvant RT. RT as an important part of the treatment. Local recurrence and
regional recurrence were signiﬁcantly increased with the addition of RT.
http://dx.doi.org/10.1016/j.rpor.2013.03.578
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Introduction. Neuroﬁbromatosis I (NF-I) or VonRecklinghausen’s disease represents around 85%of all types of neuroﬁbromatosis. It
has an autosomal dominant inheritance. Clinically we can observe malignant peripheral nerve sheath tumors (MPNST) accounts
for about 5-10% of all soft tissue sarcomas affecting mainly young people. Malignant Tumor Triton (MTT) is located in the head,
neck, extremities and trunk; lungs are the most common site of metastasis. It has an aggressive biological behavior with poor
survival at 5 years. Prognosis depends on the location, histological grade and completeness of surgical margins. Gold standard
treatment is surgery followby radiotherapy: external beamradiotherapy (EBRT), brachytherapyor intraoperative radiation therapy
(IORT). The chemotherapy role is controversial. Clinical case 31- year- oldmandiagnosed ofNF-I. In 2011he referred appearance of
a 6 cms tumor inhis left knee supportedwith schwanomaand itwas completely resected.Oneyear later, the same lesionappeared
again. New complete surgery was done but surgical margins were affected and the pathological results were compatibles with
Malignant Schwanoma with rabdomyoblastic differentiation (MTT). He didn’t present disease in other distant sites so we decided
complete surgery with margins expansion plus IORT achiving a total dose of 17,5Gy After surgery, margins were completeness
and he received a complementary EBRT until achieve a total dose of 50Gy presenting grade 2-3 skin toxicity resolved with daily
local cures
Conclusion. MTT represents a very unusual entity, but malignant differentiation occurs in approximately 75% of these patients. It’s
an aggressive tumor with a high rate of local recurrence so the treatment must be multidisciplinary. In this case, due to patient’s
age, affected initial surgical margins and reviewing the literature, we decided combined radical treatment with complete surgery
+ IORT, followed by EBRT achieving a total dose higher than 60Gy for decreasing risk of local recurrence.
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